Sasitorn D. Siritho

2 Wanglang Road
Bangkok, 10700, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Multimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.

Multimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.

Journal: Multiple sclerosis and related disorders

Published: July 04, 2026

Corrigendum to "The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study" [Multiple Sclerosis and Related Disorders, Volume 70, February 2023, 104511].

Corrigendum to "The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study" [Multiple Sclerosis and Related Disorders, Volume 70, February 2023, 104511].

Journal: Multiple sclerosis and related disorders

Published: June 09, 2026

Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.

Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.

Journal: Multiple sclerosis and related disorders

Published: April 24, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 16, 2026

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 26, 2026

Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Journal: Journal of clinical medicine research

Published: February 07, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 04, 2026

Therapeutic Plasma Exchange in Thailand: A 10-Year Retrospective Analysis.

Therapeutic Plasma Exchange in Thailand: A 10-Year Retrospective Analysis.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: September 29, 2025

The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis.

The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis.

Journal: Scientific reports

Published: September 17, 2025

Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region.

Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region.

Journal: Multiple sclerosis and related disorders

Published: August 17, 2025

Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder.

Unemployment, work hour reduction, and income loss: An international, multicentered, cross-sectional study of neuromyelitis optica spectrum disorder.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 09, 2025

Real-world data and patient perspectives on the impact of multiple sclerosis, neuromyelitis optica spectrum disorder, and related disorders on employment.

Real-world data and patient perspectives on the impact of multiple sclerosis, neuromyelitis optica spectrum disorder, and related disorders on employment.

Journal: Multiple sclerosis and related disorders

Published: April 02, 2025

Showing 1-12 of 74

Last Updated: 09/26/2026